Video Education and Behaviour Contract to Optimize Adherence in Renal Transplants

NCT03540121 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 173

Last updated 2024-08-16

No results posted yet for this study

Summary

This study aims to test the effectiveness of an electronic-based video intervention and behavioral contract on improving medication adherence among kidney transplant recipients.

Conditions

  • Kidney Transplantation
  • Medication Adherence

Interventions

BEHAVIORAL

Video education + adherence contract

Participants will receive standard education along with the home-based video education plus an adherence contract. Following the baseline assessment, access to videos will be provided electronically so that the patient can watch them at home. The videos will be initially viewed in the following order: Video 1: Introduction, Video 2: Medications, Video 3: Your New Life. Approximately one month after transplant, after the video series has been viewed in its entirety, participants will receive an email link inviting participants to reflect on their goals about transplantation and pledging to taking their medications as directed. The contract will be non-enforceable, but it will provide patients with the opportunity to formally commit to a goal of taking the medications as prescribed. At 3 months, and 12 months, the participant will have the opportunity to reflect and modify adherence goals as desired.

Sponsors & Collaborators

  • Saskatchewan Health Authority - Regina Area

    collaborator OTHER
  • Southern Alberta Transplant Program

    collaborator UNKNOWN
  • University of Illinois Health Sciences System

    collaborator UNKNOWN
  • American Society of Transplantation Research Network

    collaborator UNKNOWN
  • University of Alberta Transplant Recipient Program

    collaborator UNKNOWN
  • Vancouver Coastal Health

    collaborator OTHER_GOV
  • Providence Health, St. Pauls Hospital - Renal Transplant Program

    collaborator UNKNOWN
  • University of Saskatchewan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03540121 on ClinicalTrials.gov